Clinical Trial Update: Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the effect of 1,25-dihydroxyvitamin D3 on insulin secretion and muscle strength in pre-diabetic individuals was terminated with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pre-diabetes
• Type 2 Diabetes Mellitus Risk

Drugs mentioned

• 1,25-dihydroxyvitamin D3 (1,25-dihydroxyvitamin D3)

Snippet

Sponsor: Mayo Clinic | Conditions: Pre-Diabetic | Phase 1 | Status: TERMINATED | Results posted: 2022-04-18